these folks get a minus D In performance and communication. Incredibly disheartening.
With todays news :First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv) as well as todays news: Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting perhaps signaling a reversal in our complains as expressed above! The road ahead certainly looks more promising! :-)
There is certainly some, even great improvement in performance, and even greater in communications, even if by paid informationals: Pleasing Signs As A Number Of Insiders Buy Gamida Cell Stock editorial-team@simplywallst.com (Simply Wall St) Fri, September 29, 2023 at 1:10 PM GMT+3 https://finance.yahoo.com/news/pleasing-signs-number-insiders-buy-101021778.html Exposure for a (relative) tiny company is important! .